Spect is a leading data science company at the forefront of end-to-end eye disease screening solutions. With a mission to prevent blindness by detecting eye diseases early and creating a platform for healthcare data analytics, Spect is dedicated to revolutionizing eyecare. The company recognizes the eye as the Check Engine Light of the Body™, serving as a vital indicator for not only eye diseases but also whole-body conditions like stroke and Parkinson's.

Spect's telemedicine platform, bolstered by human-in-the-loop assistance, empowers medical assistants to effortlessly capture retinal images and receive diagnostic reports. Looking forward, Spect plans to leverage artificial intelligence to capture and grade images. This pioneering approach fills a crucial healthcare gap for patients and clinics, resulting in exceptional service and financial outcomes.

The Spect team comprises experts with diverse experience from world-renowned organizations. Led by CEO Mike Ricci and hardware co-founder Michael Leung, the team includes accomplished professionals in fields such as product development, software, design, clinical expertise, and more. Spect's remarkable achievements have earned them recognition, including being chosen as one of the most promising digital health companies of 2022 by CB Insights and winning the 2022 UCSF Health Hub Digital Health Awards for Rising Stars.

With a commitment to excellence and innovation, Spect is set to revolutionize eyecare and improve patient outcomes. Explore career opportunities and find out more about Spect's groundbreaking solutions on their website